Industry

Company aims to launch one new product or indication every 1.5 years on average, bolstered by external innovation Phase III assets xevinapant and evobrutinib are expected to drive next wave of launches Focused leadership approach to pipeline enrichment builds on expertise in key biology and therapeutic areas as well as technological capabilities Not intended for … [Read more…]

Company aims to launch one new product or indication every 1.5 years on average, bolstered by external innovation Phase III assets xevinapant and evobrutinib are expected to drive next wave of launches Focused leadership approach to pipeline enrichment builds on expertise in key biology and therapeutic areas as well as technological capabilities Not intended for … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Biodefense Market, By Product Type, By Application, By End-Use, and By Region Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. The global biodefense market size is expected to reach USD 32.80 Billion in 2030 and register a revenue CAGR of 8.7% over the forecast period, according to latest report. Companies Mentioned … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Parkinson’s Disease Treatment: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. Global Parkinson’s Disease Treatment Market to Reach $6.7 Billion by 2027 In the changed post COVID-19 business landscape, the global market for Parkinson’s Disease Treatment estimated at US$4.6 Billion in the year 2020, is projected to reach a revised … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Cannabidiol: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. Global Cannabidiol Market to Reach $13.4 Billion by 2027 In the changed post COVID-19 business landscape, the global market for Cannabidiol estimated at US$5 Billion in the year 2020, is projected to reach a revised size of US$13.4 Billion by 2027, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Europe Genotyping Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product and Services, Technology Application, and End User” report has been added to ResearchAndMarkets.com’s offering. The genotyping market in Europe is expected to grow from US$ 6,178.64 million in 2022 to US$ 19,073.60 million by 2028. It is estimated … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Pharmacovigilance & Drug Safety Software Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Pharmacovigilance & Drug Safety Software Market is projected to reach USD 940.58 million by 2027 from USD 426.74 million in 2021, at a CAGR of 14.07% during the forecast period. Market … [Read more…]

LONDON–(BUSINESS WIRE)–Ellipses Pharma Limited (“Ellipses”), a global drug development company focused on accelerating the development of new oncology treatments, is delighted to announce that it will be presenting clinical updates covering two of its assets at the San Antonio Breast Cancer Symposium (SABCS), taking place between 6 – 10 December 2022 in San Antonio, Texas, … [Read more…]

LONDON–(BUSINESS WIRE)–#businesstravel–November is Men’s Health Awareness Month with Movember and International Men’s Day being recognised globally, both highlighting the importance of supporting the health and wellbeing of men. To mark these key calendar dates, International SOS shares guidance on how organisations can increase awareness of physical and mental health issues among men and encourage early … [Read more…]

CAMBRIDGE, England–(BUSINESS WIRE)–#CBT—ieso, a healthcare company pioneering digital therapeutics in mental health that improve patient access and outcomes, announced today that it has been selected as the Most Transformative Digital Healthcare Company at the 2022 OBN Awards, held at the Royal Lancaster in London. The OBN Awards, now in their 14th year, celebrate innovation and … [Read more…]